Predicting the Intensity of Psychedelic-Induced Mystical and Challenging Experience in a Healthy Population: An Exploratory Post-Hoc Analysis.

Ko, Kwonmok; Carter, Ben; Cleare, Anthony J; Rucker, James J

Ko, Kwonmok; Carter, Ben; Cleare, Anthony J; Rucker, James J.

Afiliación

Ko K; Centre for Affective Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, SE5 8AF, UK.
Carter B; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, SE5 8AF, UK.
Cleare AJ; Centre for Affective Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, SE5 8AF, UK.
Rucker JJ; South London and Maudsley NHS Foundation Trust, Bethlem Royal Hospital, Beckenham, BR3 3BX, UK.

Neuropsychiatr Dis Treat ; 19: 2105-2113, 2023.

Article en En | MEDLINE | ID: mdl-37818448

Palabras clave

challenging experience; mystical experience; psilocybin; psychedelic therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Neuropsychiatr Dis Treat Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google